Deep Imaging to Dissect Microvascular Contributions to White Matter Degeneration in Rodent Models of Dementia
- PMID: 37094035
- PMCID: PMC10460612
- DOI: 10.1161/STROKEAHA.122.037156
Deep Imaging to Dissect Microvascular Contributions to White Matter Degeneration in Rodent Models of Dementia
Abstract
The increasing socio-economic burden of Alzheimer disease (AD) and AD-related dementias has created a pressing need to define targets for therapeutic intervention. Deficits in cerebral blood flow and neurovascular function have emerged as early contributors to disease progression. However, the cause, progression, and consequence of small vessel disease in AD/AD-related dementias remains poorly understood, making therapeutic targets difficult to pinpoint. Animal models that recapitulate features of AD/AD-related dementias may provide mechanistic insight because microvascular pathology can be studied as it develops in vivo. Recent advances in in vivo optical and ultrasound-based imaging of the rodent brain facilitate this goal by providing access to deeper brain structures, including white matter and hippocampus, which are more vulnerable to injury during cerebrovascular disease. Here, we highlight these novel imaging approaches and discuss their potential for improving our understanding of vascular contributions to AD/AD-related dementias.
Keywords: animal; arterioles; brain; cerebrovascular disease; hippocampus; imaging; white matter.
Figures



Similar articles
-
Overlap between pathology of Alzheimer disease and vascular dementia.Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13 Suppl 3:S115-23. doi: 10.1097/00002093-199912003-00017. Alzheimer Dis Assoc Disord. 1999. PMID: 10609690 Review.
-
Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathy.J Neuropathol Exp Neurol. 2023 May 25;82(6):457-466. doi: 10.1093/jnen/nlad026. J Neuropathol Exp Neurol. 2023. PMID: 37071794 Free PMC article.
-
Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.Alzheimers Res Ther. 2019 Jul 27;11(1):64. doi: 10.1186/s13195-019-0521-0. Alzheimers Res Ther. 2019. PMID: 31351489 Free PMC article.
-
Alzheimer's disease in late-life dementia: a minor toxic consequence of devastating cerebrovascular dysfunction.Med Hypotheses. 2008;70(4):866-75. doi: 10.1016/j.mehy.2007.07.027. Epub 2007 Sep 6. Med Hypotheses. 2008. PMID: 17825499
-
Alzheimer disease and cerebrovascular pathology: an update.J Neural Transm (Vienna). 2002 May;109(5-6):813-36. doi: 10.1007/s007020200068. J Neural Transm (Vienna). 2002. PMID: 12111471 Review.
Cited by
-
The Cerebrovascular Side of Plasticity: Microvascular Architecture across Health and Neurodegenerative and Vascular Diseases.Brain Sci. 2024 Sep 28;14(10):983. doi: 10.3390/brainsci14100983. Brain Sci. 2024. PMID: 39451997 Free PMC article. Review.
-
The pathogenesis of cerebral small vessel disease and vascular cognitive impairment.Physiol Rev. 2025 Jul 1;105(3):1075-1171. doi: 10.1152/physrev.00028.2024. Epub 2025 Feb 18. Physiol Rev. 2025. PMID: 39965059 Free PMC article. Review.
-
SERS-Based Optical Nanobiosensors for the Detection of Alzheimer's Disease.Biosensors (Basel). 2023 Sep 11;13(9):880. doi: 10.3390/bios13090880. Biosensors (Basel). 2023. PMID: 37754114 Free PMC article. Review.
-
Hope for vascular cognitive impairment: Ac-YVAD-cmk as a novel treatment against white matter rarefaction.PLoS One. 2024 Apr 17;19(4):e0299703. doi: 10.1371/journal.pone.0299703. eCollection 2024. PLoS One. 2024. PMID: 38630707 Free PMC article.
-
Insights into the transcriptomic heterogeneity of brain endothelial cells in normal aging and Alzheimer's disease.Neural Regen Res. 2026 Feb 1;21(2):569-576. doi: 10.4103/NRR.NRR-D-24-00695. Epub 2024 Dec 16. Neural Regen Res. 2026. PMID: 39688567 Free PMC article.
References
-
- Leijenaar JF, van Maurik IS, Kuijer JPA, van der Flier WM, Scheltens P, Barkhof F, Prins ND. Lower cerebral blood flow in subjects with Alzheimer’s dementia, mild cognitive impairment, and subjective cognitive decline using two-dimensional phase-contrast magnetic resonance imaging. Alzheimer’s & dementia. 2017;9:76–83 - PMC - PubMed
-
- Wardlaw JM, Smith C, Dichgans M. Small vessel disease: Mechanisms and clinical implications. Lancet Neurology. 2019;18:684–696 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical